This disclosure relates to food products. In particular this disclosure relates to dog food products. In one embodiment, the food compositions comprise ingredients based on the principles of dosha. In one embodiment, the compositions comprise sprouted ingredients providing higher levels of nutrition and value.

This disclosure relates to food products. In particular this disclosure relates to dog food products. In one embodiment, the food compositions comprise ingredients based on the principles of dosha. In one embodiment, the compositions comprise sprouted ingredients providing higher levels of nutrition and value.

Obtention of aromatic compounds extracted from Punica granatum, Thymus vulgaris and Allium sativum and which have genome interaction capacity for regeneration of the enterocyte, and their use in the manufacture of functional additives for use in animal feed.

Obtention of aromatic compounds extracted from Punica granatum, Thymus vulgaris and Allium sativum and which have genome interaction capacity for regeneration of the enterocyte, and their use in the manufacture of functional additives for use in animal feed.

This invention describes novel food bait compositions that can be used alone or in combination with blends of attractive compounds to induce attraction and feeding by mice and rats. Said compositions and blends can be used to induce mice and rats to be captured in traps or to approach and remain in a location where they will be exposed to a rodenticide.

This invention describes novel food bait compositions that can be used alone or in combination with blends of attractive compounds to induce attraction and feeding by mice and rats. Said compositions and blends can be used to induce mice and rats to be captured in traps or to approach and remain in a location where they will be exposed to a rodenticide.

The present invention discloses a system and method for increasing the lifespan and quality of life of human beings and other mammals. This discloses methods for preparing and delivering various health and longevity compositions. The compositions of the present invention are selected and designed for the purpose of efficiently delivering health and longevity enhancing therapies through oral supplementation, misting, nasal spray, suppository, etc. An existing compound known to have capacity for life extending potential, rapamycin, is combined with a non-toxic therapeutic anabolic hormone, e.g., DHEA, and cannabidiol (CBD) to enable absorption and effect. These three compounds work together to dramatically improve both the quality of life in aging humans and other mammals as well as extending the life of humans potentially up to 120 healthy years. One preferred embodiment provides a method for continuous low dose supplementation, e.g., incorporated in or with a daily meal. This invention not only resolves the issue of anti-aging of higher life forms, without toxicity, but provides for an improved method for absorption.

Obtention of aromatic compounds extracted from Punica granatum, Thymus vulgaris and Allium sativum and which have genome interaction capacity for regeneration of the enterocyte, and their use in the manufacture of functional additives for use in animal feed.

Obtention of aromatic compounds extracted from Punica granatum, Thymus vulgaris and Allium sativum and which have genome interaction capacity for regeneration of the enterocyte, and their use in the manufacture of functional additives for use in animal feed.

The present disclosure provides a feed additive for domesticated animals that is capable of increasing feed performance, as well as associated methods for promoting growth and zootechnical performance in domesticated animals. The animal feed additive provided contains marrubiin, related compounds or biologically acceptable salts thereof, and in some embodiments Total Lignans standardized in the contents of Furoguaiacin-like compounds and Guaiacin-like compounds. The present disclosure also describes methods for improving growth via the dietary inclusion of marrubiin, related compounds or biologically acceptable salts thereof, and in certain embodiments Total Lignans standardized in Furoguaiacin-like compounds and Guaiacin-like compounds.